Adenomyosis
Conditions
Interventions
Fertility group1:Enantone 3.75mg
Fertility group2:Enantone 1.88mg
Small Uterus and fertility needless group1:Mirena
Small Uterus and fertility needless group2:oral contraceptive
Small Uterus and fertility needless group3:San Jie Zhen Tong capsule
Large Uterus and fertility needless group1:Enantone 3.75mg
Large Uterus and fertility needless group2:Enantone 1.88mg
Sponsors
Obstetrics and Gynecology Hospital of Fudan University
Eligibility
Sex/Gender
Female
Age
25 Years to 50 Years
Inclusion criteria
Inclusion criteria: Be voluntory to this trial and sign the consent form; Women age between 25 to 50; B-Ultrasound indicate adenomyosis; Dysmenorrhea; Maxium diameter of Uterine is less than or equal to 10cm.
Exclusion criteria
Exclusion criteria: Younger than 25, elder than 50 or postmenopausal women; Be allergic to or contraindicated to studied drugs; Be pregnant, having accute genital tract inflamation or other gynecological malignant diseases such as ovarian cancer; Receive progestin treatment within a month, receive GnRH-a within three months, or underwent uterus within six months; Severe hepatic and renal dysfunction; CA125>300U/mL.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CA125;FSH;LH;E2;uterrine size; | — |
Countries
China
Contacts
Public ContactHua Keqin
Outcome results
None listed